We serve Chemical Name:2,3,6,7,10,11-Triphenylenehexol CAS:4877-80-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2,3,6,7,10,11-Triphenylenehexol
CAS.NO:4877-80-9
Synonyms:Triphenylene-2,3,6,7,10,11-hexaol;Triphenylene-2,3,6,7,10,11-hexol;2,3,6,7,10,11-Hexahydroxytriphenylene;2,3,6,7,10,11-Triphenylenehexol
Molecular Formula:C18H12O6
Molecular Weight:324.284
HS Code:2906299090
Physical and Chemical Properties:
Melting point:>300ºC
Boiling point:776.3±55.0 °C at 760 mmHg
Density:1.8±0.1 g/cm3
Index of Refraction:1.998
PSA:121.38000
Exact Mass:324.063385
LogP:1.90
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Triphenylene-2,3,6,7,10,11-hexaol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,3,6,7,10,11-Triphenylenehexol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Triphenylene-2,3,6,7,10,11-hexol Use and application,Triphenylene-2,3,6,7,10,11-hexaol technical grade,usp/ep/jp grade.
Related News: A week after the memo was released to employees, Reuters reported that the Justice Department had launched a criminal investigation focused on the Branchburg plant. That same day, May 27, Lilly reported to the U.S. Securities and Exchange Commission that it had received a subpoena from the department seeking documents related to the factory. 2,3,6,7,10,11-Triphenylenehexol manufacturer The American Heart Association explains that metabolic syndrome — a grouping of five different conditions — elevates the risk for such illnesses. Abdominal obesity is one such condition; the other four include high blood sugar, high triglycerides, high blood pressure and low levels of good” HDL cholesterol.
Bariatric surgery — including sleeve gastrectomy and gastric bypass — offers an opportunity to reduce such risk by helping patients achieve considerable weight loss, the investigators said.
In fact, the study team noted that bariatric surgery is the standard of care for severely obese patients. Severe obesity is defined as having a body mass index (BMI) of 40, or a BMI of 35 and up alongside obesity-related complications such as diabetes.
Using insurance claims data, Schimpke and his team focused on a pool of nearly 1.8 million patients across the United States who were severely obese — and therefore eligible for bariatric surgery — in the decade beginning 2010.
Of those, roughly 100,000 actually underwent bariatric surgery during that time frame. But procedure patterns varied widely by state.
For example, while between roughly 9% and 10.4% of eligible patients in New Jersey, Rhode Island and Delaware opted for surgery, less than 3% did so in West Virginia, Alabama and Arkansas.
Overall, the researchers determined that the lowest in opt-in rates by region was the Midwest, where just over 4% of eligible patients underwent surgery, despite the fact that nearly 34% of Midwesterners are obese (making the region home to the highest overall obesity rates in the country).
By contrast, the highest opt-in surgery rate (nearly 8%) was seen in the Northeast region, where the overall obesity rate is lower (29%).
The findings were presented last week at a virtual meeting of the American Society for Metabolic and Bariatric Surgery. Such research is considered preliminary until published in a peer-reviewed journal.
“There are likely several contributing factors to the wide variation in utilization,” said Schimpke. He highlighted differences in: levels of access to medical care; beliefs and attitudes among patients and referring physicians; number of available hospitals and surgeons; and insurance coverage requirements.
Schimpke also pointed to the “negative psycho-social connotation associated with bariatric surgery among both physicians/practitioners and patients, which needs to be addressed with strategic campaigns detailing the safety and efficacy of bariatric surgery. 2,3,6,7,10,11-Triphenylenehexol supplier With the onset of the DMF system for APIs, the concentration of the API industry will further increase. 2,3,6,7,10,11-Triphenylenehexol vendor Slow business: Due to fear — and travel warnings — fewer people want to travel to China. 2,3,6,7,10,11-Triphenylenehexol factory With the onset of the DMF system for APIs, the concentration of the API industry will further increase.
Bariatric surgery — including sleeve gastrectomy and gastric bypass — offers an opportunity to reduce such risk by helping patients achieve considerable weight loss, the investigators said.
In fact, the study team noted that bariatric surgery is the standard of care for severely obese patients. Severe obesity is defined as having a body mass index (BMI) of 40, or a BMI of 35 and up alongside obesity-related complications such as diabetes.
Using insurance claims data, Schimpke and his team focused on a pool of nearly 1.8 million patients across the United States who were severely obese — and therefore eligible for bariatric surgery — in the decade beginning 2010.
Of those, roughly 100,000 actually underwent bariatric surgery during that time frame. But procedure patterns varied widely by state.
For example, while between roughly 9% and 10.4% of eligible patients in New Jersey, Rhode Island and Delaware opted for surgery, less than 3% did so in West Virginia, Alabama and Arkansas.
Overall, the researchers determined that the lowest in opt-in rates by region was the Midwest, where just over 4% of eligible patients underwent surgery, despite the fact that nearly 34% of Midwesterners are obese (making the region home to the highest overall obesity rates in the country).
By contrast, the highest opt-in surgery rate (nearly 8%) was seen in the Northeast region, where the overall obesity rate is lower (29%).
The findings were presented last week at a virtual meeting of the American Society for Metabolic and Bariatric Surgery. Such research is considered preliminary until published in a peer-reviewed journal.
“There are likely several contributing factors to the wide variation in utilization,” said Schimpke. He highlighted differences in: levels of access to medical care; beliefs and attitudes among patients and referring physicians; number of available hospitals and surgeons; and insurance coverage requirements.
Schimpke also pointed to the “negative psycho-social connotation associated with bariatric surgery among both physicians/practitioners and patients, which needs to be addressed with strategic campaigns detailing the safety and efficacy of bariatric surgery. 2,3,6,7,10,11-Triphenylenehexol supplier With the onset of the DMF system for APIs, the concentration of the API industry will further increase. 2,3,6,7,10,11-Triphenylenehexol vendor Slow business: Due to fear — and travel warnings — fewer people want to travel to China. 2,3,6,7,10,11-Triphenylenehexol factory With the onset of the DMF system for APIs, the concentration of the API industry will further increase.
